Stock Options and Restricted Stock - Summary of Activity for Stock Option Programs (Detail) - $ / shares		3 Months Ended				12 Months Ended
		Jun. 30, 2024		Mar. 31, 2024		Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options beginning balance		946,054	[1]	959,522		1,061,849
Granted		0		0		0
Cancelled		(146)		(85)		(33,382)
Exercised	[2]	(2,867)		(13,383)		(68,945)
Number of options ending balance		943,041	[1]	946,054	[1]	959,522
Options exercisable		854,742	[1]			697,647
Exercise price per share, lower range limit beginning balance		$ 2.14	[1]	$ 2.14		$ 2.14
Exercise price per share, upper range limit beginning balance		9.38	[1]	9.38		9.38
Exercise price per share, granted		0		0		0
Exercise price per share, lower range limit ending balance		2.14	[1]	2.14	[1]	2.14
Exercise price per share, upper range limit ending balance		9.38	[1]	9.38	[1]	9.38
Exercise price per share, option exercisable lower range limit		2.14	[1]			2.14
Exercise price per share, option exercisable upper range limit		9.38	[1]			9.38
Weighted average exercise price, beginning balance		6.51	[1]	6.51		6.51
Weighted average exercise price, granted		0		0		0
Weighted average exercise price, cancelled		4.89		4.89		6.8
Weighted average exercise price, exercised	[2]	6.14		6.61		6.44
Weighted average exercise price, ending balance		6.51	[1]	6.51	[1]	6.51
Weighted average exercise price, options exercisable		6.52	[1]			6.51
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price per share, cancelled						4.89
Exercise price per share, exercised	[2]	4.89		4.89		4.89
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price per share, cancelled		4.89		4.89		9.38
Exercise price per share, exercised	[2]	$ 7.25		$ 7.25		$ 7.25

[1] The aggregate intrinsic value of outstanding options, which represents the difference between the price of the Company’s common stock at June 30, 2024 and the related exercise price of the underlying options, was $1.1 million for outstanding options and $1.0 million for vested options as of June 30, 2024. The remaining contractual life was 5.6 years for outstanding options and 5.5 years for vested options at June 30, 2024

[2] The aggregate intrinsic value of exercised options, which represents the difference between the price of the Company’s common stock at the exercise date and the related exercise price of the underlying options, was less than $0.1 million for the three and six months ended June 30, 2024 and was $0.1 million for the year ended December 31, 2023.